MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma
2020 · Cancer Treatment Reviews · 160 citations
https://doi.org/10.1016/j.ctrv.2020.102024
S
Sarah Derks
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
187
Papers
2.9K
Citations
24
h-index
41
i10-index
Sarah Derks is an academic researcher from Twitter (United States). The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Esophageal Cancer Research and Treatment & Cancer Immunotherapy and Biomarkers. The author has an h-index of 24, co-authored 159 publications.
ORCID: 0000-0002-4547-7457Papers by this author
worksResistance mechanisms to HER2-targeted therapy in gastroesophageal adenocarcinoma: A systematic review
2022 · Cancer Treatment Reviews · 41 citations
https://doi.org/10.1016/j.ctrv.2022.102418
Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands
2024 · JAMA Surgery · 19 citations
https://doi.org/10.1001/jamasurg.2023.7872
Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study
2023 · Gastric Cancer · 18 citations
https://doi.org/10.1007/s10120-023-01404-2
The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally
2022 · BMC Cancer · 14 citations
https://doi.org/10.1186/s12885-022-09689-9
A systematic review of HER2 blockade for the curative treatment of gastroesophageal adenocarcinoma: Successes achieved and opportunities ahead
2021 · Cancer Treatment Reviews · 8 citations
https://doi.org/10.1016/j.ctrv.2021.102249
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat